Registry of restriction intentions until outcome
Registry of restriction intentions until outcome
Registry of restriction intentions until outcome
The registry of restriction intentions until outcome lists the intentions and Annex XV restriction proposals received by ECHA.
A restriction proposal may be prepared by a Member State or by ECHA at the request of the Commission or on its own initiative for substances in the Authorisation List. It is a legal requirement for a Member State to notify ECHA of its intention to prepare a restriction dossier. The advance notice enables interested parties to plan and prepare for commenting later on.
Interested parties can follow the progress of a proposal through the restriction process, from the notification of the intention to the adoption of the final opinions by the Committee for Risk Assessment (RAC) and the Committee for Socio-economic Analysis (SEAC), and the adoption of the restriction by the European Commission.
Stakeholders are encouraged to submit any relevant information to the dossier submitters during the preparation of the restriction proposal and during the consultations. Information to motivate any exemptions to the scope described in the intention is particularly useful to receive in the preparatory phase of the dossier.
1-methyl-2-pyrrolidone
EC / List no: 212-828-1 CAS no: 872-50-4CLP Annex VI Index number | 606-021-00-7 |
Further substance information | |
Submitter(s) | Netherlands |
Details on the scope of restriction | Manufacturing, and all industrial and professional uses of the substance, where workers’ exposure exceeds a level specified in the restriction. |
Reason for restriction | NMP is a substance used in numerous industrial applications and in numerous products. Releases during industrial processes cause worker exposure. Our main concern is the use of NMP in coatings and cleaners for consumers and professionals. At this moment it is not clear if combined exposures may lead to unacceptable risks introducing some uncertainty or lack of possible exposure scenarios in the risk assessment. This possible concern remains difficult to quantify at this stage. It, however, can also not be stated that there is no concern at all. We consider the restriction the most appropriate risk management option because in our view authorization is less proportional and less practical. |
Remarks | The dossier was resubmitted on 9 August 2013, as it was not found to be in conformity by the Risk Assessment Committee in June 2013 |
Status | Commission decided |
Date of intention | 04-Jun-2012 |
Expected date of submission | 09-Aug-2013 |
Withdrawal date | |
Reason for withdrawal | |
Start of Call for Evidence consultation | |
Deadline for comments on the Call for Evidence | |
Start of second Call for Evidence consultation | |
Deadline for comments on the second Call for Evidence | |
Start of third Call for Evidence consultation | |
Deadline for comments on the third Call for Evidence | |
Restriction report (and annexes) | |
Information note on restriction report | |
Start of Annex XV report consultation | 18-Sep-2013 |
1st deadline for comments on Annex XV report | |
Final deadline for comments on Annex XV report | 18-Mar-2014 |
Comments on Annex XV report | |
Opinion of RAC (and minority positions) | |
Draft opinion of SEAC | |
RAC & SEAC (draft) Background document (and annexes) | |
Start of SEAC draft opinion consultation | 16-Sep-2014 |
Deadline for comments on SEAC draft opinion | 14-Nov-2014 |
Comments on SEAC draft opinion | |
Compiled RAC and SEAC opinion (and minority positions) | |
Final background document (and annexes) | |
Adopted restriction/Commission communication | |
Latest update | 21-Dec-2018 |
First published | 28-Feb-2018 |
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.